These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23439582)

  • 1. Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis.
    Harris VK; Donelan N; Yan QJ; Clark K; Touray A; Rammal M; Sadiq SA
    Mult Scler; 2013 Oct; 19(11):1462-72. PubMed ID: 23439582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of oligodendrocyte and neuronal marker genes predicts the clinical onset of autoimmune encephalomyelitis and indicates the effectiveness of multiple sclerosis-directed therapeutics.
    Evangelidou M; Karamita M; Vamvakas SS; Szymkowski DE; Probert L
    J Immunol; 2014 May; 192(9):4122-33. PubMed ID: 24683189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
    Hu X; Qin X
    Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
    Chowdhury SA; Lin J; Sadiq SA
    Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid microvesicles are a marker and therapeutic target for neuroinflammation.
    Verderio C; Muzio L; Turola E; Bergami A; Novellino L; Ruffini F; Riganti L; Corradini I; Francolini M; Garzetti L; Maiorino C; Servida F; Vercelli A; Rocca M; Dalla Libera D; Martinelli V; Comi G; Martino G; Matteoli M; Furlan R
    Ann Neurol; 2012 Oct; 72(4):610-24. PubMed ID: 23109155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of calcifying nanoparticles in the etiology of multiple sclerosis.
    Can Demirdöğen B
    Med Hypotheses; 2019 Jul; 128():25-27. PubMed ID: 31203904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetuin-A deficiency protects mice from Experimental Autoimmune Encephalomyelitis (EAE) and correlates with altered innate immune response.
    Harris VK; Bell L; Langan RA; Tuddenham J; Landy M; Sadiq SA
    PLoS One; 2017; 12(4):e0175575. PubMed ID: 28388685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lesional accumulation of RhoA(+) cells in brains of experimental autoimmune encephalomyelitis and multiple sclerosis.
    Zhang Z; Schittenhelm J; Meyermann R; Schluesener HJ
    Neuropathol Appl Neurobiol; 2008 Apr; 34(2):231-40. PubMed ID: 17983427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARδ deficient mice develop elevated Th1/Th17 responses and prolonged experimental autoimmune encephalomyelitis.
    Kanakasabai S; Walline CC; Chakraborty S; Bright JJ
    Brain Res; 2011 Feb; 1376():101-12. PubMed ID: 21192919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
    Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
    J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of neuropsin in the pathogenesis of experimental autoimmune encephalomyelitis.
    Terayama R; Bando Y; Yamada M; Yoshida S
    Glia; 2005 Nov; 52(2):108-18. PubMed ID: 15920728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis.
    Romme Christensen J; Börnsen L; Khademi M; Olsson T; Jensen PE; Sørensen PS; Sellebjerg F
    Mult Scler; 2013 Jun; 19(7):877-84. PubMed ID: 23178691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.
    Augutis K; Axelsson M; Portelius E; Brinkmalm G; Andreasson U; Gustavsson MK; Malmeström C; Lycke J; Blennow K; Zetterberg H; Mattsson N
    Mult Scler; 2013 Apr; 19(5):543-52. PubMed ID: 23069872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid derived from progressive multiple sclerosis patients promotes neuronal and oligodendroglial differentiation of human neural precursor cells in vitro.
    Cristofanilli M; Cymring B; Lu A; Rosenthal H; Sadiq SA
    Neuroscience; 2013 Oct; 250():614-21. PubMed ID: 23876320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis.
    Zagon IS; Rahn KA; Turel AP; McLaughlin PJ
    Exp Biol Med (Maywood); 2009 Nov; 234(11):1383-92. PubMed ID: 19855075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minocycline effects on the cerebrospinal fluid proteome of experimental autoimmune encephalomyelitis rats.
    Stoop MP; Rosenling T; Attali A; Meesters RJ; Stingl C; Dekker LJ; van Aken H; Suidgeest E; Hintzen RQ; Tuinstra T; van Gool A; Luider TM; Bischoff R
    J Proteome Res; 2012 Aug; 11(8):4315-25. PubMed ID: 22768796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bri2-23 is a potential cerebrospinal fluid biomarker in multiple sclerosis.
    Harris VK; Diamanduros A; Good P; Zakin E; Chalivendra V; Sadiq SA
    Neurobiol Dis; 2010 Oct; 40(1):331-9. PubMed ID: 20600910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE).
    Musgrave T; Benson C; Wong G; Browne I; Tenorio G; Rauw G; Baker GB; Kerr BJ
    Brain Behav Immun; 2011 Nov; 25(8):1677-88. PubMed ID: 21723939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal hepatocyte growth factor levels correlate negatively with disease activity in multiple sclerosis.
    Müller AM; Jun E; Conlon H; Sadiq SA
    J Neuroimmunol; 2012 Oct; 251(1-2):80-6. PubMed ID: 22771249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.
    Sellebjerg F; Börnsen L; Khademi M; Krakauer M; Olsson T; Frederiksen JL; Sørensen PS
    Neurology; 2009 Dec; 73(23):2003-10. PubMed ID: 19996075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.